Solasia Pharma K.K.
4597.T
Price:
$32
Market Cap:
$8.18B
Solasia Pharma K.K. develops and commercializes drugs in the field of oncology in Japan and other Asian countries. The company offers SP-03 (episil oral liquid) for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and radiotherapy for cancer; and SP-01 (Sancuso), a transdermal delivery system that delivers granisetron, an anti-emetic into the patient's bloodstream for the treatment of chemotherapy induced nausea and vomiting. It is also developing SP-02 (Darinaparsin), a mitochondrial-targeted agent that has completed phase III clinical study to treat various hematologic and solid cancers; and SP-04 a chemotherapy induced peripheral neur...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-03-27
Stock Exchange
JPX
Ticker
4597.T
PE Ratio
[-3.57]
ROE
[-137.19%]
Current Ratio
[3.42]
Dividend Yield
[0%]
Enterprise Value
[6.81B]
Dividend History
The ROE as of December 2025 (TTM) for Solasia Pharma K.K. (4597.T) is -137.19%
According to Solasia Pharma K.K.’s latest financial reports and current stock price. The company's current ROE is -137.19%. This represents a change of 244.93% compared to the average of -39.77% of the last 4 quarters.
Solasia Pharma K.K. (4597.T) Historical ROE (quarterly & annually)
How has 4597.T ROE performed in the past?
The mean historical ROE of Solasia Pharma K.K. over the last ten years is -68.72%. The current -137.19% ROE has changed 99.63% with respect to the historical average. Over the past ten years (40 quarters), 4597.T's ROE was at its highest in in the September 2017 quarter at 1.97%. The ROE was at its lowest in in the December 2024 quarter at -92.56%.
Average
-68.72%
Median
-61.89%
Minimum
-167.76%
Maximum
-13.82%
Solasia Pharma K.K. (4597.T) ROE by Quarter and Year
Discovering the peaks and valleys of Solasia Pharma K.K. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 318.73%
Maximum Annual ROE = -13.82%
Minimum Annual Increase = -78.56%
Minimum Annual ROE = -167.76%
| Year | ROE | Change |
|---|---|---|
| 2024 | -167.76% | 182.87% |
| 2023 | -59.31% | -38.04% |
| 2022 | -95.72% | -0.03% |
| 2021 | -95.75% | -15.30% |
| 2020 | -113.04% | 318.73% |
| 2019 | -27.00% | -20.99% |
| 2018 | -34.17% | 110.54% |
| 2017 | -16.23% | 17.44% |
| 2016 | -13.82% | -78.56% |
| 2015 | -64.46% | -75.86% |
Solasia Pharma K.K. (4597.T) Average ROE
How has 4597.T ROE performed in the past?
The current ROE of Solasia Pharma K.K. (4597.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-107.60%
5-year avg
-106.31%
10-year avg
-68.72%
Solasia Pharma K.K. (4597.T) ROE vs. Peers
How is 4597.T’s ROE compared to its peers?
Solasia Pharma K.K.’s ROE is greater than MedRx Co., Ltd (-65.52%), less than Morishita Jintan Co., Ltd. (3.80%), greater than Data Horizon Corporation (-170.64%), greater than Modalis Therapeutics Corporation (-49.60%), greater than Chordia Therapeutics Inc. (-59.40%), greater than ADR120S, Inc. (-133.55%), greater than SymBio Pharmaceuticals Limited (-123.34%), greater than BrightPath Biotherapeutics Co., Ltd. (-97.87%), greater than Chiome Bioscience Inc. (-62.16%), greater than OncoTherapy Science, Inc. (-90.96%),
| Company | ROE | Market cap |
|---|---|---|
| -65.52% | $6.53B | |
| 3.80% | $8.81B | |
| -170.64% | $6.35B | |
| -49.60% | $4.69B | |
| -59.40% | $7.24B | |
| -133.55% | $7.66B | |
| -123.34% | $4.83B | |
| -97.87% | $4.72B | |
| -62.16% | $7.62B | |
| -90.96% | $6.77B |
Build a custom stock screener for Solasia Pharma K.K. (4597.T) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Solasia Pharma K.K. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Solasia Pharma K.K. (4597.T) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Solasia Pharma K.K. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Solasia Pharma K.K.'s ROE?
How is the ROE calculated for Solasia Pharma K.K. (4597.T)?
What is the highest ROE for Solasia Pharma K.K. (4597.T)?
What is the 3-year average ROE for Solasia Pharma K.K. (4597.T)?
What is the 5-year average ROE for Solasia Pharma K.K. (4597.T)?
How does the current ROE for Solasia Pharma K.K. (4597.T) compare to its historical average?